235 related articles for article (PubMed ID: 30570758)
21. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment.
Johnson R; Halder G
Nat Rev Drug Discov; 2014 Jan; 13(1):63-79. PubMed ID: 24336504
[TBL] [Abstract][Full Text] [Related]
22. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
23. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
Crawford JJ; Bronner SM; Zbieg JR
Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112
[No Abstract] [Full Text] [Related]
24. The Hippo Pathway in Prostate Cancer.
Salem O; Hansen CG
Cells; 2019 Apr; 8(4):. PubMed ID: 31018586
[TBL] [Abstract][Full Text] [Related]
25. The Hippo-YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After Injury.
Deng F; Wu Z; Zou F; Wang S; Wang X
Front Cell Dev Biol; 2022; 10():894737. PubMed ID: 35927987
[TBL] [Abstract][Full Text] [Related]
26. The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises.
Ortega Á; Vera I; Diaz MP; Navarro C; Rojas M; Torres W; Parra H; Salazar J; De Sanctis JB; Bermúdez V
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008857
[TBL] [Abstract][Full Text] [Related]
27. The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin.
Rognoni E; Walko G
Cells; 2019 May; 8(5):. PubMed ID: 31058846
[TBL] [Abstract][Full Text] [Related]
28. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell.
Plouffe SW; Lin KC; Moore JL; Tan FE; Ma S; Ye Z; Qiu Y; Ren B; Guan KL
J Biol Chem; 2018 Jul; 293(28):11230-11240. PubMed ID: 29802201
[TBL] [Abstract][Full Text] [Related]
29. DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins.
Nguyen HT; Kugler JM; Cohen SM
PLoS One; 2017; 12(1):e0169587. PubMed ID: 28061504
[TBL] [Abstract][Full Text] [Related]
30. What do mechanotransduction, Hippo, Wnt, and TGFβ have in common? YAP and TAZ as key orchestrating molecules in ocular health and disease.
Morgan JT; Murphy CJ; Russell P
Exp Eye Res; 2013 Oct; 115():1-12. PubMed ID: 23792172
[TBL] [Abstract][Full Text] [Related]
31. Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway.
Wang Y; Cao W; Cui J; Yu Y; Zhao Y; Shi J; Wu J; Xia Z; Yu B; Liu J
Cell Physiol Biochem; 2018; 51(2):842-853. PubMed ID: 30466081
[TBL] [Abstract][Full Text] [Related]
32. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.
Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K
Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202
[TBL] [Abstract][Full Text] [Related]
33. YAP/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth.
Low BC; Pan CQ; Shivashankar GV; Bershadsky A; Sudol M; Sheetz M
FEBS Lett; 2014 Aug; 588(16):2663-70. PubMed ID: 24747426
[TBL] [Abstract][Full Text] [Related]
34. Role of the transcriptional coactivators YAP/TAZ in liver cancer.
Zhang S; Zhou D
Curr Opin Cell Biol; 2019 Dec; 61():64-71. PubMed ID: 31387016
[TBL] [Abstract][Full Text] [Related]
35. The Hippo Pathway: Biology and Pathophysiology.
Ma S; Meng Z; Chen R; Guan KL
Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
[TBL] [Abstract][Full Text] [Related]
36. Hippo and TGF-β interplay in the lung field.
Saito A; Nagase T
Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L756-67. PubMed ID: 26320155
[TBL] [Abstract][Full Text] [Related]
37. New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities?
Shreberk-Shaked M; Oren M
Mol Oncol; 2019 Jun; 13(6):1335-1341. PubMed ID: 31050214
[TBL] [Abstract][Full Text] [Related]
38. Dysfunctional Mechanotransduction through the YAP/TAZ/Hippo Pathway as a Feature of Chronic Disease.
Cobbaut M; Karagil S; Bruno L; Diaz de la Loza MDC; Mackenzie FE; Stolinski M; Elbediwy A
Cells; 2020 Jan; 9(1):. PubMed ID: 31936297
[TBL] [Abstract][Full Text] [Related]
39. Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine.
Dey A; Varelas X; Guan KL
Nat Rev Drug Discov; 2020 Jul; 19(7):480-494. PubMed ID: 32555376
[TBL] [Abstract][Full Text] [Related]
40. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
Zhao B; Lei QY; Guan KL
Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
